Daniel Omstead
Managing Partner
Medicine
 Regeneus
Sweden
Biography
Daniel Omstead, Ph.D., is President and CEO and President of H&Q Lifesciences Investors and H&Q Healthcare Investors; two NYSE listed closed-end mutual funds that make venture and public equity investments in small, emerging healthcare-related companies. Previously, he was President and CEO of Reprogenesis, Inc. a private development stage biotech regenerative medicine company, which merged with two other companies to form Curis, Inc., and was Senior Vice President, R&D at Cytotherapeutics, Inc., a public biotech company in CNS therapies. He holds Doctoral and Master’s Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University.
Research Interest
MEDICINE
